JP3SBIO@EC2609A

PUXING ENERGY

STARCOIN GROUP

KNOWLEDGE ATLAS

EASY SMART GP

WORLD SUPER

XL2CSOPSMSN-U

PPS INT'L

LAP KEI ENGRG

CHINA FORTUNE

XL2CSOPSMSN

588860

159837

159849

560600

159992

520880

512010

01530

516500

516930

159859

159102

520690

513120

513060

159506

159316

Sunshine Guojian Pharmaceutical's Attributable Profit Soars 311%

marketscreener

ICBCCS SSE STAR Biology and Medicine ETF

E Fund CSI Biotechnology Theme ETF

China Merchants CSI Biotechnology Theme ETF

Founder Fubon CSI Medicine and Medical Device Innovation ETF

Yinhua CSI Innovative Drugs Industry ETF

Ping An CSI Medicine and Medical Device Innovation ETF

Hwabao WP Hang Seng SCHK Innovative Drug Select ETF

E Fund CSI 300 Health Care ETF

3SBIO

ChinaAMC CSI Biotechnology Theme ETF

ChinaAMC Hang Seng Biotechnology Technology ETF(QDII)

Minsheng Royal CSI Biotechnology Theme ETF

Tianhong CNI BIOMEDICINE ETF

China Southern Hang Seng Biotech ETF(QDII)

Sunshine Guojian Pharmaceutical

Huaan Hang Seng Biotech ETF

Bosera Hang Seng SCHK Innovative Drug Select ETF

Guotai CSI Bio-medicine ETF

ChinaAMC SSE STAR Biology and Medicine ETF

GF CSI HK Innovative Drugs Industry ETF(QDII)

Bosera Hang Seng Health Care ETF(QDII)

Fullgoal Hang Seng SCHK Innovative Drug & Healthcare ETF

ChinaAMC SSE Health Care ETF Initiating Fund

Penghua SSE STAR Biology and Medicine ETF

E Fund Hang Seng SCHK Innovative Drug ETF

Sunshine Guojian Pharmaceutical's Attributable Profit Soars 311%

蔓迪国际

3SBIO opened high today at 3.36%, closing up 10.25% at 24.96 yuan, with a trading volume of 38.3572 million shares and a total transaction value of 922 million yuan. The company announced that it will distribute all of its shares in Mandi International to eligible shareholders through a physical distribution method. Mandi International is a professional consumer pharmaceutical company focused on skin health and weight management

AASTOCKS

3SBIO rose 10.25% in half a day, distributing all shares of Mandi International

3SBio (SEHK:1530) reported FY 2025 H1 results with revenue of ¥4.4b and EPS of ¥0.57, maintaining a strong net margin of 47.9%. Despite a significant earnings growth of 305.8% over the past year, forecasts predict a decline in revenue and earnings over the next three years. The stock trades at a low P/E of 5.9x, well below the industry average, raising questions about future profitability. Investors are divided, with bullish views on current margins and bearish concerns over projected declines.

Simplywall

3SBio (SEHK:1530) Trailing 48% Net Margin Challenges Bearish Earnings Decline Narrative

3SBio Inc. reported earnings results for the full year ended December 31, 2025. For the full year, the company reported sales was CNY 17,695.75 million compared to CNY 9,107.98 million a year ago. Net income was CNY 8,482.16 million compared to CNY 2,090.32 million a year ago.Basic earnings per share from continuing operations was CNY 3.51 compared to CNY 0.86 a year ago. Diluted earnings per share from continuing operations was CNY 3.43 compared to CNY 0.85 a year ago.

3SBio Inc. Reports Earnings Results for the Full Year Ended December 31, 2025

513700

3SBio Nearly Doubles Revenue and Quadruples Profit in 2025, Keeps Dividend Steady

Tip Ranks

Penghua CSI HK Connect Health Care Composite ETF

3SBio Nearly Doubles Revenue and Quadruples Profit in 2025, Keeps Dividend Steady

Alphamab Oncology Names Former 3SBio Executive as CFO

E Fund CSI HK Equities Medical and Health Integration ETF

Ping An CSI HK Equities Medical and Health Integration ETF

Yinhua CSI HK Equities Medical and Health Integration ETF

ALPHAMAB-B

First Trust NYSE Arca Biotech Index Fd

Alphamab Oncology Names Former 3SBio Executive as CFO

03896

09988

00700

03858

09926

09961

06809

On March 18th, Hong Kong stocks closed today with the three major indices slightly higher, with the Hang Seng Index rising 0.61% to successfully return to 26,000 points. In terms of sectors, the retail sector performed strongly driven by consumer recovery, while the oil and gas sector declined due to fluctuations in oil prices. The heavyweight stock Alibaba rose 2.30%, supporting the index. The market was active, with significant movements in the artificial intelligence concept and optical fiber sectors, as funds speculated on the pace of economic recovery and key macro indicators

- On March 18, Hong Kong's stock indices saw slight gains while maintaining a volatile pattern, with overall market sentiment remaining stable.  
- The Hang Seng Index rose by 0.61% to 26,025.42 points, staying above 26,000 but still below previous highs, while the Hang Seng Tech Index increased marginally by 0.01%.  
- Retail stocks surged amid expectations of consumer recovery, whereas the oil and gas sector weakened due to international price fluctuations.

Market Heartbeat

KINGSOFT CLOUD

BABA-W

TENCENT

JIAXIN INTL RES

AKESO

TRIP.COM-S

MONTAGE TECH

Hang Seng Index

Hong Kong stock market closing | Hang Seng Index rose 0.61% to stand above 26,000 points, with the retail sector leading the gains. Alibaba rose 2.3%

09618

09888

00883

01385

01171

09995

On March 18th, during the Hong Kong stock market trading, the three major indices collectively strengthened, with the Hang Seng Index rising by 0.87%, indicating a moderate rebound in risk appetite. The retail sector performed well, with leading stocks like Alibaba and JD leading the gains, boosting market sentiment; however, the oil and gas sector generally retreated due to the weakening of international oil prices. Among popular stocks, Shanghai Fudan surged by 12.73%, and MINIMAX-W increased by over 23%. Investors are currently focusing on macro indicators such as unemployment rates and manufacturing PMI, with market volatility influenced by external environmental factors

- On March 18, Hong Kong's three main indices gained slightly, reflecting a modest rebound in risk appetite.  
- The Hang Seng Index rose 0.87% to 26,092.72 points, while the Hang Seng Tech and the China Enterprises Index increased by 0.36% and 0.34%, respectively, with all indices maintaining their positions within recent ranges.  
- Retail stocks surged due to consumption recovery expectations, led by Alibaba and JD.com, while oil and gas exploration faced pressure from declining international oil prices.

JD-SW

BIDU-SW

CNOOC

SHANGHAI FUDAN

YANKUANG ENERGY

REMEGEN

SPDR S&P Retail ETF

VanEck Retail ETF

KraneShares 2x Long BABA Daily ETF

JD HEALTH

KraneShares 2x Long JD Daily ETF

MINIMAX-W

ALI HEALTH

JD.com

Alibaba

JD LOGISTICS

BABA 2x Long Daily ETF - GraniteShares

Global X E-commerce ETF

Amplify Online Retail ETF

Krne Csi China Internet

Hong Kong stock market intraday | Hang Seng Index up 0.87%, retail sector leads with Alibaba up 3.34%

09903

02685

09660

00632

00467

As of noon, the three major indices of the Hong Kong stock market rebounded collectively, with the Hang Seng Index rising 1.56% to 25,804.66 points. The internet content and retail sectors performed strongly, with Tencent Holdings leading the blue chips with a 5.72% increase, and Alibaba rising 3.03%. Although market bullish sentiment has rebounded, the index has not yet confirmed an upward breakout. In the afternoon, attention will be on whether funds can continue to increase and challenge previous highs

- As of midday, Hong Kong's three major indices continued their rebound, with the Hang Seng Index at 25,804.66 points, up 1.56%.  
- The internet content and information sector led gains, driven by positive earnings expectations from major companies like Tencent and Baidu, while the oil and gas exploration sector faced declines amid weakening oil prices.  
- Overall, investor sentiment is influenced by macroeconomic indicators, with a focus on liquidity conditions and the ongoing economic recovery amidst external market uncertainties.

ILUVATAR COREX

QUANTGROUP

HORIZONROBOT-W

CHK OIL

UNITEDENERGY GP

Hang Seng Composite Index

Tencent

Tencent Holdings Limited

Hwabao CSI HK Equities Internet ETF

E Fund CSI HK Connect Internet ETF

Hong Kong Stock Midday Review | Hang Seng Index rises 1.56%, led by the internet sector, Tencent rises 5.72%

02618

00HSI

688331

The Hang Seng Index closed up 1.72%, and the Hang Seng Tech Index rose 3.15%. JD LOGISTICS rose over 20%, RemeGen rose over 10%, and 3SBIO rose over 8%. Yangtze Optical Fibre and Cable fell over 7%, and Sinopec Oilfield Service fell over 2%

Wallstreetcn

RemeGen

The Hang Seng Index closed up 1.72%, with the innovative drug sector leading the gains

562050

UBS released a research report listing investment ratings and target prices for healthcare stocks. Hengrui Pharma is rated as Buy, with the target price raised from RMB 96.9 to RMB 98.3; Hansoh Pharma is rated as Buy, with the target price raised from RMB 48.2 to RMB 51.5; Sino Biopharmaceutical is rated as Buy, with a target price of RMB 12.2; 3SBIO is rated as Buy, with a target price of RMB 41; CSPC Pharma is rated as Neutral, with the target price raised from RMB 10 to RMB 10.9; Simcere Pharma is rated as Buy, with a target price of RMB 16.3; United Lab is rated as Buy, with a target price of RMB 18.9

CSPC Innovation

Dacheng CSI All Share Health Care Equipment and Services ETF

Guotai SSE STAR Brand Name Drug ETF

China Universal CNI HK Connect Innovative Drugs Industry ETF

China Universal 800 Health Care ETF

HANSOH PHARMA

SIMCERE PHARMA

UNITED LAB

CSPC PHARMA

Huatai-PB Hang Seng Innovative Drugs Industry ETF(QDII)

Hengrui Pharma

Hwabao WP CSI Pharmaceuticals ETF

SBP GROUP

UBS Investment Ratings and Target Prices for Healthcare Stocks (Table)

601607

02607

Results from a Phase 2 trial reveal promising findings for patients who cannot undergo standard reperfusion therapies. This data was presented at the International Stroke Conference and highlights the efficacy of LT3001 in providing significant functional improvements for patients with disabling Acute Ischemic Stroke (AIS). The trial showcased that LT3001 delivers meaningful outcomes for patients ineligible for standard treatments.

Unusual Whales

Shanghai Pharma

SH PHARMA

Breakthrough trial LT3001 shows functional improvement in patients with acute ischemic stroke, ineligible for standard therapies. Presented at conference.

Hong Kong stocks continued their upward trend on July 28, with the cryptocurrency, innovative drug, gaming, and insurance sectors performing well. Hong Kong's &#34;Stablecoin Ordinance&#34; will officially take effect on August 1, marking the countdown to stablecoin issuance; the innovative drug sector was boosted by Hengrui Pharmaceuticals securing a $12 billion order; insurance stocks extended their gains as industry anti-internal competition and interest rate cuts improved profit prospects; gaming stocks benefited from Macau's July gaming revenue exceeding expectations and Thailand's withdrawal of the casino bill.

HENGRUI PHARMA

INNOVENT BIO

OSL GROUP

CPIC

SUNSHINE INS

SANDS CHINA LTD

Sands China

WYNN MACAU

CR HOLDINGS

CHINA LIFE

China Life

MELCO INT'L DEV

GUOTAI JUNAN I

AIA-R

AIA Group

SJM HOLDINGS

Hot Trades in Hong Kong Stocks (7.28)｜Cryptocurrency, Innovative Drugs, Insurance, and Gaming Sectors Shine, Hengrui Pharmaceuticals Soars 15% at Midday

Hong Kong stocks' innovative medicine sector surges 66%, three-pronged approach ignites the golden track

WUXI APPTEC

WuXi AppTec

WUXI BIO

WuXi Biologics

DUALITYBIO-B

INNOCARE

InnoCare Pharma

JOINN

Hong Kong stocks' innovative drugs surge 66%! Three major catalysts ignite the 'golden track', can we still get on board in the second half of the year?

JP3SBIO@EC2609A(27196.HK)

JP3SBIO@EC2609A Stock Performance Chart

Sunshine Guojian Pharmaceutical's Attributable Profit Soars 311%

3SBIO rose 10.25% in half a day, distributing all shares of Mandi International

3SBio (SEHK:1530) Trailing 48% Net Margin Challenges Bearish Earnings Decline Narrative

3SBio Inc. Reports Earnings Results for the Full Year Ended December 31, 2025

3SBio Nearly Doubles Revenue and Quadruples Profit in 2025, Keeps Dividend Steady